Indeed, genetic silencing and pharmacological inhibition of Bmi1 induced apoptosis and senescence, enhanced chemosensitivity, and diminished invasive and metastatic potentials, thus ultimately compromised cancer progression [9, 19, 20]. This evidence concerns the gene BMI1 and cancer.